Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Phcog.Net JOURNAL OF PHARMACOLOGY AND PHARMACOTHERAPEUTICS Volume 13 · Issue 2 2022 · pp. 113–206
    Search this issue

    Cover: Journal of Pharmacology and Pharmacotherapeutics

    Journal of Pharmacology and Pharmacotherapeutics

    Volume 13, Issue 2

    2022 · pp. 113–206 · 12 articles

    Volume
    13
    Issue
    2
    Published
    2022
    Pages
    113–206
    Articles
    12
    Sections
    3
    ISSN
    ISSN: Print - 0976-500X, Online - 0976-5018
    Journal
    J Pharmacol. Pharmacother.

    In this issue

    Review Article

    1. Review

      Medical Professionalism and Ethics

      Mira K. Desai, Jigar Dilipkumar Kapadia

      pp. 113–118 · DOI: 10.1177/0976500X221111448 · Published 2022

      Frequent media reports of disputes between medical teachers, resident doctors, and patients have been disturbing thus indicating an increasing gap and decline in the values of the profession. The foundation of medical pr

    2. Review

      Secukinumab: A Silver Lining in Dermatology

      Dhanaraj Manoharan, Ravi Vignesh N., Srinivasan Shreya, Saravanan Suzsmi L.

      pp. 119–124 · DOI: 10.1177/0976500X221105921 · Published 2022

      Secukinumab, a fully human monoclonal antibody, is a biological agent that targets interleukin-17A. Secukinumab is used in the management of the common dermatological entity - plaque-type psoriasis and its various types,

    3. Review

      The Role of TGF-β in Cognitive Decline Associated with Radiotherapy in Brain Tumor

      G. S. Swarna Bindu, Dithu Thekkekkara, T. Lakshmi Narayanan, Jiju Narayanan, Sri Harsha Chalasani, S. N. Manjula

      pp. 125–134 · DOI: 10.1177/0976500X221107503 · Published 2022

      Cognitive decline is a late adverse event in brain tumor survivors. The patients receiving radiation treatment exhibit a wide range of damage and impairment in attention, memory, and executive function compared to the un

    Research Article

    1. Article

      In Silico Modeling and Docking Analysis of CTX-M-5, Cefotaxime-Hydrolyzing β-Lactamase from Human-Associated Salmonella Typhimurium

      S. K. Md. Jasmine, Vidya Sagar Reddy G., Neelima Gorityala, Someswar Rao Sagurthi, Sandhya Mungapati, Kota Neela Manikanta, Uday Sankar Allam

      pp. 135–147 · DOI: 10.1177/0976500X221109721 · Published 2022

      Objective: To computationally model the CTX-M-5 β-lactamase and establish its structure, which is exclusively present in human-associated Salmonella. Methods: The CTX-M-5 aminoacid sequence (Uniprot ID:O65975) of Salmone

    2. Article

      The Effects of Deoxyelephantopin on the Akt/mTOR/P70S6K Signaling Pathway in MCF-7 Breast Carcinoma Cells In Vitro

      Wan Failiza Wan Mohamad Fazil, Azimah Amanah, Muhammad Asyraf Abduraman, Shaida Fariza Sulaiman, Habibah Abdul Wahab, Mei Lan Tan

      pp. 148–159 · DOI: 10.1177/0976500X221114003 · Published 2022

      Objective: To determine the effects of deoxyelephantopin on mTOR and its related target molecules (Akt/mTOR/P70S6K) in the ER-positive breast cancer cell line. Materials and Methods: Primary in silico simulations were de

    3. Article

      Application of Physiologically Based Pharmacokinetic Modeling of Lamotrigine Using PK-Sim in Predicting the Impact of Drug Interactions and Dosage Adjustment

      Mohammed Farhan, Prathvi Rani, Fatimazahra Moledina, Thomas George, Hari Prabhath Tummala, Surulivelrajan Mallayasamy

      pp. 160–166 · DOI: 10.1177/0976500X221111455 · Published 2022

      Objectives: To build a lamotrigine (LTG) physiologically based pharmacokinetic (PBPK) model (LTG PBPK) and compare it to the clinical data from South Asian Indian patients and use this model to understand the drug intera

    4. Article

      Pharmacokinetics of a Novel Sustained-Release Vitamin C Oral Tablet: A Single Dose, Randomized, Double-Blind, Placebo-Controlled Trial

      Rajat Shah, Shefali Thanawala, Ramapalaniappan Abiraamasundari

      pp. 167–174 · DOI: 10.1177/0976500X221111669 · Published 2022

      Objectives: To evaluate the pharmacokinetics of a novel sustained-release oral tablet (C-Fence, Inventia Healthcare Limited, Mumbai, India). Methods: We conducted a randomized, placebo-controlled, parallel-design, 500 mg

    5. Article

      The Association Between Serum Vitamin D Levels and Serum Cathelicidin Antimicrobial Peptide (CAMP) Levels Among Tuberculosis Patients in Comparison with Control Subjects

      Kiran Belur, Prema Arunachalam, Jamuna Rani Raveendran

      pp. 175–181 · DOI: 10.1177/0976500X221105760 · Published 2022

      Objectives: To compare the serum vitamin D and serum cathelicidin antimicrobial peptide (CAMP) levels among tuberculosis patients and healthy subjects and to determine the association between serum vitamin D and cathelic

    6. Article

      Antiemetic Efficacy of Prophylactic Ondansetron Versus Ondansetron with Dexamethasone Combination Therapies in Women Undergoing Breast Surgeries: A Randomized Controlled Trial

      Apoorva Devarahosahally Shivanna, Reena R. Kadni, Syed Farzan Tausif, Varghese K. Zachariah

      pp. 182–189 · DOI: 10.1177/0976500X221105758 · Published 2022

      Objective: To compare the prophylactic antiemetic efficacy of ondansetron monotherapy with that of the combination of ondansetron and dexamethasone in the prevention on postoperative nausea and vomiting (PONV) in breast

    7. Article

      Curcumin-Impregnated Drug Delivery Systems May Show Promise in the Treatment of Diseases Secondary to Traumatic Brain Injury: Systematic Review

      İbrahim Yilmaz, Numan Karaarslan, Hakan Somay, Hanefi Ozbek, Ozkan Ates

      pp. 190–196 · DOI: 10.1177/0976500X221112479 · Published 2022

      Objective: To find out whether curcumin can be effective in the treatment of traumatic brain injury (TBI). Methods: A comprehensive and systematic literature search in the PubMed electronic database was performed. Descri

    8. Article

      Adverse Drug Reactions to Antifungals Used in the Management of COVID-19 Associated Rhino-Orbito-Cerebral Mucormycosis

      Smrati Tiwari, Zahaan Vakil

      pp. 197–202 · DOI: 10.1177/0976500X221105759 · Published 2022

      Objectives: To determine the incidence and frequency of adverse drug reactions (ADRs) to find out factors, if any contributing to the same, while also exploring the use of amphotericin B deoxycholate as a cheaper and saf

    Case Report

    1. Article

      Low-Dose Tramadol-Induced Seizure: A Case Report

      Himadri Sekhar Dasgupta, Debashis Priyadarshan Sahoo, Bhupen Barman, Dhriti Brahma

      pp. 203–206 · DOI: 10.1177/0976500X221107494 · Published 2022

      Tramadol is a weak mu (µ) opioid receptor agonist that acts by inhibiting serotonin and norepinephrine uptake. Tramadol undergoes extensive hepatic metabolism by a number of pathways, including CYP2D6 and CYP3A4, and by